Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pressure Rises To Pass India’s Draft Drug Policy

This article was originally published in PharmAsia News

Executive Summary

NEW DELHI - Indian Chemicals Minister Ram Vilas Paswan is making an all out effort to get the country's draft pharmaceutical policy cleared by the Group of Ministers in its next meeting
Advertisement

Related Content

India Strives To Create Regulatory Body For Devices With Help From Industry
India Strives To Create Regulatory Body For Devices With Help From Industry
India Creates New Department Of Pharmaceuticals To Coordinate Industry Regulation
India Creates New Department Of Pharmaceuticals To Coordinate Industry Regulation
Indian Drug Makers Seek Relief From Price Control
Indian Drug Makers Seek Relief From Price Control
India’s Draft Pharma Policy In Trouble Again
India’s Draft Pharma Policy In Trouble Again
India’s Draft Pharma Policy Could Pass On April 30
PharmAsia News India Pharma Roundup: Jubilant Organosys, Drug Price Cuts, Pharma Advisory Forum, Ranbaxy
Advertisement
UsernamePublicRestriction

Register

SC068140

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel